Liver disease was associated with reduced protection against influenza-associated hospitalization following influenza vaccination.

A trial of the influenza antiviral baloxavir suggests that the drug could be used as post-exposure prophylaxis to prevent ...

Prof. Si Longlong's team from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences constructed a ...

A single-dose baloxavir treatment can reduce influenza transmission from index patients to household contacts.

The CENTERSTONE trial [NCT03969212] was a global phase III trial investigating the efficacy of single-dose Xofluza, taken ...

One dose of the antiviral baloxavir marboxil lowers the chance of transmitting the influenza virus to family members by about ...

A phase 3b trial finds that a single dose of baloxavir reduces household transmission of influenza, offering new insights for ...

Arnold S. Monto, MD, from the University of Michigan School of Public Health in Ann Arbor, and colleagues examined the efficacy of single-dose baloxavir treatment to reduce influenza transmission ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed by Pfizer and BioNTech, which may offer quicker production and greater efficacy than ...

Nasal Spray H5N1 Avian Influenza Vaccine Developed Apr. 8 ... Current Antivirals Likely Less Effective Against Severe Infection Caused by Bird Flu Virus in Cows' Milk Mar. 17, 2025 — Existing ...